Compare SW & HOLX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | SW | HOLX |
|---|---|---|
| Founded | 1934 | 1985 |
| Country | Ireland | United States |
| Employees | 97000 | N/A |
| Industry | | Medical Electronics |
| Sector | | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 20.3B | 16.9B |
| IPO Year | N/A | 1995 |
| Metric | SW | HOLX |
|---|---|---|
| Price | $41.42 | $76.02 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 12 | 13 |
| Target Price | $53.25 | ★ $77.89 |
| AVG Volume (30 Days) | 4.6M | ★ 9.3M |
| Earning Date | 04-30-2026 | 04-30-2026 |
| Dividend Yield | ★ 4.30% | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 0.79 |
| Revenue | N/A | ★ $4,100,500,000.00 |
| Revenue This Year | $4.50 | $4.74 |
| Revenue Next Year | $3.10 | $5.03 |
| P/E Ratio | ★ $38.98 | $96.23 |
| Revenue Growth | N/A | ★ 1.74 |
| 52 Week Low | $32.73 | $51.90 |
| 52 Week High | $52.65 | $76.07 |
| Indicator | SW | HOLX |
|---|---|---|
| Relative Strength Index (RSI) | 49.66 | 69.09 |
| Support Level | $40.97 | $75.10 |
| Resistance Level | $44.44 | N/A |
| Average True Range (ATR) | 1.12 | 0.19 |
| MACD | 0.43 | 0.03 |
| Stochastic Oscillator | 59.89 | 95.19 |
Smurfit WestRock PLC manufactures corrugated packaging and consumer packaging, such as folding cartons and paperboard. operates a vertically integrated system supplying wood and recovered fiber to produce various grades of board, which are then converted into packaging products. Its main packaging categories include corrugated containers and consumer packaging, with additional products such as solidboard, kraft paper, graphic board, paper sacks, and bag-in-box packaging. The company's geographical segments include North America (including the U.S., Canada and Mexico), Europe, the Middle East and Africa and Asia-Pacific, and Latin America. The majority of the company's revenue is derived from product sales in the North American region.
Hologic manufactures proprietary products for the healthcare needs of women. The company operates in four segments: diagnostics (44% of total sales), breast health (38%), surgical (16%), and skeletal health (2%). While the company traditionally focused on breast health, the acquisition of Gen-Probe put greater emphasis on commercial diagnostics. The United States accounts for the largest portion of the firm's revenue (69%), followed by Europe (20%), Asia (8%), and other international markets (3%). Hologic is headquartered in Bedford, Massachusetts.